Aytu Biopharma (AYTU) Inventory Average (2015 - 2026)
Aytu Biopharma (AYTU) posted quarterly Inventory Average of $8.1 million for Q1 2026, down 27.22% year-over-year from $11.1 million in Q1 2025, and down 14.08% quarter-over-quarter from $9.4 million in Q4 2025.
Aytu Biopharma (AYTU) Inventory Average (2015 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Inventory Average for 12 consecutive years, with $8.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average fell 27.22% year-over-year to $8.1 million; the TTM figure through Mar 2026 stood at $8.1 million (down 27.22% YoY), while the FY2025 annual figure was $11.8 million, down 2.32% from the prior year.
- Inventory Average declined to $8.1 million in Q1 2026 per AYTU's latest filing, from $9.4 million in the prior quarter.
- Across five years, Inventory Average topped out at $15.2 million in Q1 2022 and bottomed at $8.1 million in Q1 2026.
- Historically, Inventory Average has averaged $12.0 million across 5 years, with a median of $12.4 million in 2022.
- Annual changes were most pronounced in 2022 — Inventory Average declined 27.36% — and 2023, when it rose 5.23%.
- Aytu Biopharma's Inventory Average stood at $12.9 million in 2022, then grew by 0.57% to $13.0 million in 2023, then slipped by 12.1% to $11.4 million in 2024, then dropped by 17.82% to $9.4 million in 2025, then slipped by 14.08% to $8.1 million in 2026.
- Business Quant data shows AYTU's Inventory Average at $8.1 million in Q1 2026, $9.4 million in Q4 2025, and $10.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 824.00 Mn |
| 10 | Aytu Biopharma | 24.49 Mn | -2.22 Mn | 7.60 Mn | 8.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.06 Mn |
| Dec 31, 2025 | 9.38 Mn |
| Sep 30, 2025 | 10.77 Mn |
| Jun 30, 2025 | 11.25 Mn |
| Mar 31, 2025 | 11.07 Mn |
| Dec 31, 2024 | 11.41 Mn |
| Sep 30, 2024 | 11.94 Mn |
| Jun 30, 2024 | 12.67 Mn |
| Mar 31, 2024 | 13.10 Mn |
| Dec 31, 2023 | 12.98 Mn |
| Sep 30, 2023 | 12.48 Mn |
| Jun 30, 2023 | 12.82 Mn |
| Mar 31, 2023 | 13.29 Mn |
| Dec 31, 2022 | 12.91 Mn |
| Sep 30, 2022 | 11.86 Mn |
| Jun 30, 2022 | 12.37 Mn |
| Mar 31, 2022 | 15.22 Mn |
| Dec 31, 2021 | 16.44 Mn |
| Sep 30, 2021 | 16.33 Mn |
| Dec 31, 2020 | 9.03 Mn |